hit tracker
prime news list

all information about tech and other

The Roller Coaster Virtual Ride Study brings new perspectives on Migraine

The Roller Coaster Virtual Ride Study brings new perspectives on Migraine

By Denise Mann
HealthDay Reporter

THURSDAY 2021, July 22, 2021 (HealthDay News) – Russian coasters are racing up and down, running fast and fast again and again, but if you’re one of the millions of people who get it migraines, the danger is not worth the excitement.

A new study by German researchers has shown that people who receive migraines feel more motion sickness and after dizziness on a virtual roller coaster, compared to those who do not suffer from these blind headaches.

These symptoms were directly related to key changes brain the researchers said these areas and these studies could be investigated to relieve headaches.

“Migraine patients reported more dizziness and motion sickness, as well as longer duration and intensity of symptoms on a roller coaster ride and the brains of migraine patients reacted differently,” said Dr. Arne May, a professor of neurology at the University. Hamburg. “It simply came to our notice then [symptoms], but also in specific activations of the cerebral cerebellum and frontal gyrus. “

The cerebellum of the brain helps regulate balance and the anterior circumference is responsible for visual processing.

More than a cautionary tale about the dangers of roller coasters for people with migraine history, the new findings add to their understanding of migraines as a sensory disorder and may pave the way for treatments that correct these symptoms.

For the study, 20 people with a history of migraine and 20 people with no such history watched videos to experience a virtual roller coaster ride while researchers used functional MRI scans to track brain activity.

No one experienced migraines during the virtual walk, but 65% of people with migraines experienced dizziness compared to 30% of those who did not have these headaches. Moreover, people with migraines experienced symptoms longer than their non-migraine members, averaging 1 minute 19 seconds to 27 seconds, respectively. The study found that people with migraines also have more severe movement disorders.

People with migraines who increased activity in five areas of the brain were associated with migraine disability and movement sickness scores, May said. “Migraine patients process visual input differently than other people and when that happens they activate a particular network in the brain,” May explains.

Doctors who treat migration often ignore dizziness and motion sickness, even though they are part of the spectrum of symptoms of that illness. “If we explain these symptoms and show that a particular area of ​​the brain is activated during attacks, they will be better accepted,” Mayk said.

The study appears in the July 21 edition Neurology,

Headache specialists say the findings improve the understanding and burden of migraine.

“It really confirms the dizziness and migraines that migraines suffer from and that it expands our sensitivity to movement and our perception of migraines as a sensory disorder,” said Dr. Teshamae Monteith. He is an associate professor of clinical neurology and head of the headache division at Miami Miller University School of Medicine. Monteith is also a member of the American Academy of Neurology.

“Migraine is an invisible disorder, but these imaging findings validate dizziness and sensitivity to movement and lead us to think of treatment outcomes other than headaches,” Monteith said. “These symptoms can be disabling and can also occur when playing virtual reality video games.”

“Dizziness is a common symptom that informs people affected by migraines,” admitted Dr. Brian Grosberg, director of the Hartford HealthCare Headache Center in Connecticut. “The findings in this study demonstrate this experience and involve areas of the brain involved in processing.”

More information

Learn more about migraines and how they are treated American Academy of Neurology.

SOURCES: Arne May, MD, PhD, Professor, Neurology, University of Hamburg, Germany; Teshamae Monteith, MD, associate professor, clinical neurology and head, headache division, Miller University School of Medicine, University of Miami; Brian Grosberg, MD, Hartford HealthCare Headache Director, Hartford, Conn .; Neurology, July 21, 2021

Source link


Leave a Reply

Your email address will not be published. Required fields are marked *